http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
-
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
-
OncoHost to Present Proteomics-Based Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients at SITC 2023
-
Journal of Pharmaceutical & Biomedical Analysis Publishes Study Analytically Validating OncoHost's PROphet® Test as a Decision Support Tool for Metastatic NSCLC Patients
-
Standard BioTools (LAB) and SomaLogic (SLGC) to Combine in All-Stock Merger
-
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
-
OncoHost's PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer
-
Somalogic (SLGC) Announces CFO Transition
-
SomaLogic Announces Chief Financial Officer Transition
-
SomaLogic to Participate in the Jefferies Healthcare Conference
-
SomaLogic Reports First Quarter 2023 Financial Results
-
SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023
-
SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023
-
SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution
-
SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution
-
SomaLogic to Announce Fourth Quarter and Full Year 2022 Financial Results
-
SomaLogic to Announce Fourth Quarter and Full Year 2022 Financial Results
-
SomaLogic announces Certified Site expansion through world-class multiomics initiative with Group 42 Healthcare
-
SomaLogic announces Certified Site expansion through world-class multiomics initiative with Group 42 Healthcare
-
Somalogic (SLGC) Reports Prelim FY22 Revenue of $93M-$98M
-
SomaLogic Announces Preliminary Full Year 2022 Revenue and Provides Organizational and Strategic Updates
-
SomaLogic Announces Preliminary Full Year 2022 Revenue and Provides Organizational and Strategic Updates
-
SomaLogic to Participate in the 41st Annual J.P. Morgan Healthcare Conference
-
SomaLogic to Participate in the 41st Annual J.P. Morgan Healthcare Conference
-
FonesLife offers the 7,000-plex SomaScan® Platform as Japan’s first SomaLogic™ Certified Site
-
FonesLife offers the 7,000-plex SomaScan® Platform as Japan’s first SomaLogic™ Certified Site
-
Proteomics labs worldwide can now access SomaLogic’s industry-leading 7,000-plex SomaScan® Assay with the Certified Site program
-
Proteomics labs worldwide can now access SomaLogic’s industry-leading 7,000-plex SomaScan® Assay with the Certified Site program
-
Study finds proteomic risk scores for cardiovascular disease from SomaSignal® Cardio DM™ tests could support physicians in managing patient outcomes
-
Study finds proteomic risk scores for cardiovascular disease from SomaSignal® Cardio DM™ tests could support physicians in managing patient outcomes
-
SomaLogic Reports Third Quarter 2022 Financial Results
-
SomaLogic Reports Third Quarter 2022 Financial Results
-
SomaLogic Teams with Molecular Genomics to Bring the 7,000-Plex SomaScan® Platform to Asia
-
SomaLogic Teams with Molecular Genomics to Bring the 7,000-Plex SomaScan® Platform to Asia
-
OncoHost to Present Proteomics-Based Biomarker Model for Clinical Benefit to Immunotherapy in NSCLC Patients at SITC 2022
-
SomaLogic presents new research at American Heart Association Scientific Sessions that illustrates the power of proteomics in addressing cardiovascular disease
-
SomaLogic presents new research at American Heart Association Scientific Sessions that illustrates the power of proteomics in addressing cardiovascular disease
-
SomaLogic’s 7K SomaScan® Platform receives high marks in independent technical assessment by researchers at the National Institutes of Health
-
SomaLogic’s 7K SomaScan® Platform receives high marks in independent technical assessment by researchers at the National Institutes of Health
-
SomaLogic to Announce Third Quarter 2022 Financial Results
-
SomaLogic to Announce Third Quarter 2022 Financial Results
-
Somalogic (SLGC) Appoints Troy Cox as Board Chair
-
SomaLogic Announces the Appointment of Biotech Veteran Troy Cox as Executive Chairman of the Board of Directors
-
SomaLogic Announces the Appointment of Biotech Veteran Troy Cox as Executive Chairman of the Board of Directors
-
SomaLogic's Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal
-
SomaLogic's Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal
-
SomaLogic to Present at the Capital One Spatial Biology & Proteomics Summit
-
SomaLogic to Present at the Capital One Spatial Biology & Proteomics Summit
-
SomaLogic to Present at Morgan Stanley 20th Annual Global Healthcare Conference
-
SomaLogic to Present at Morgan Stanley 20th Annual Global Healthcare Conference

